skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The effect of isotope on the dosimetry of inhaled plutonium oxide

Conference ·
OSTI ID:10108381
 [1]
  1. Florida Univ., Gainesville, FL (United States)

Results of experimental studies in which animals inhaled {sup 238}PuO{sub 2} or {sup 239}PuO{sub 2} aerosols have shown that the biokinetics and associated radiation dose patterns for these two isotopes differ significantly due to differences in in-vivo solubility caused by the 260-fold difference in specific activity between {sup 238}PuO{sub 2} and {sup 239}PuO{sub 2}. We have adapted a biokinetics and dosimetry model derived from results of the ITRI dog studies to humans and have calculated dose commitments and annual limits on intake (ALI) for both Pu isotopes. Our results show that the ALI calculated in this study is one-third that for class Y {sup 238}Pu from ICRP 30, and one-half or equal to that for class Y {sup 239}Pu, depending on how activity in the thoracic lymph nodes is treated dosimetrically.

Research Organization:
Lovelace Biomedical and Environmental Research Inst., Albuquerque, NM (United States). Inhalation Toxicology Research Inst.
Sponsoring Organization:
USDOE, Washington, DC (United States)
DOE Contract Number:
AC04-76EV01013
OSTI ID:
10108381
Report Number(s):
CONF-920501-9; ON: DE92004257
Resource Relation:
Conference: 8. International Radiation Protection Association (IRPA) world congress,Vancouver (Canada),10-22 May 1992; Other Information: PBD: [1991]
Country of Publication:
United States
Language:
English